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Transcriptional activation and repression of genes that are developmentally regulated or
exhibit cell-type specific expression patterns is largely achieved by modifying the chro-
matin template at a gene locus. Complex formation of stable epigenetic histone marks,
loss or gain of DNA methylation, alterations in chromosome conformation, and specific
utilization of both proximal and distal transcriptional enhancers and repressors all con-
tribute to this process. In addition, long non-coding RNAs are a new species of regulatory
RNAs that either positively or negatively regulate transcription of target gene loci. IFN-γ
is a pro-inflammatory cytokine with critical functions in both innate and adaptive arms of
the immune system. This review focuses on our current understanding of how the chro-
matin template is modified at the IFNG locus during developmental processes leading to
its transcriptional activation and silencing.
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T HELPER CELL DIFFERENTIATION
The cytokine, IFN-γ, plays key roles in controlling infection by
intracellular pathogens, including bacteria and viruses, as well as
malignant transformation and growth (Mosmann and Coffman,
1989; Dunn et al., 2004). Two major sources of IFN-γ include T
cells and NK/NKT cells (Biron et al., 1999). Once NK/NKT cells
immigrate to the periphery, they are fully competent to produce
IFN-γ in response to a variety of extracellular stimuli. In contrast,
once T cells immigrate to the periphery, they must endure addi-
tional developmental programs before they are fully competent
to produce large quantities of IFN-γ. For the most part, develop-
mental programs in T cells are driven by a combination of T-cell
receptor signaling via antigenic stimulation and by cytokines, in
particular IL-12, produced by the innate immune system (Zhu
et al., 2010). Key transcription factors that drive the differenti-
ation process include Stat4 and T-bet (Thierfelder et al., 1996;
Szabo et al., 2000; Mullen et al., 2002). Differentiated T cells,
termed T helper 1 (Th1) and T cytotoxic 1 (Tc1) produce IFN-γ
as their predominant cytokine in response to secondary antigenic
stimulation.
At the chromatin level, this differentiation process arises from
marked epigenetic changes spanning a region greater than 100 kb
surrounding the gene that encodes IFN-γ (Zhou et al., 2004; Chang
and Aune,2005; Schoenborn et al., 2007). These epigenetic changes
include gain and loss of histone modifications associated with acti-
vation and silencing of gene transcription, respectively, changes in
DNase hypersensitivity sites, and changes in methylation (Me)
of CpG dinucleotides, a modification associated with transcrip-
tional silencing. In simple terms, a naïve T cell can be considered
a pluripotent cell capable of differentiating into multiple lineages,
including Th1, Th2 or Th17, and other variants (Weaver et al.,
2007). Upon completion of this differentiation pathway achieved
through epigenetic changes to the chromatin, differentiated cells
become fully capable of transcribing their signature cytokine,
e.g., IFNG, and silencing the cytokine genes transcribed by the
other lineages, IL4, IL13 (Th2), or IL17 (Th17) (for simplicity, the
human gene symbol convention will be used throughout, all letters
capitalized and italicized, known differences between mouse and
human will be highlighted in the text).
HISTONE CODE
Developmental processes represent heritable phenotypic changes
passed on to daughter generations in the absence of changes in the
genetic code. Th1/Th2 differentiation is an example of this process.
Thus, the term epigenetics arose to define these heritable changes
in gene expression leading to changes in phenotype in the absence
of changes in the underlying genetic code. The histones that wrap
the DNA into the chromatin fiber play key roles in these epigenetic
changes. The amino terminal “tails” of the core histones, H2A,
H2B, H3, and H4 undergo enzymatic post-translational modifi-
cations including Me, acetylation (Ac), phosphorylation, ubiqui-
tination, and sumoylation and these modifications are associated
with activation and silencing of specific genes (Rea et al., 2000;
Strahl and Allis, 2000; Turner, 2002). This recognition gave rise to
the histone code hypothesis proposing that these histone modifi-
cations at gene loci are critical for cell-type and stimulus-specific
transcriptional activation and silencing of genes. The general view
is that transcription factors that bind to specific gene loci recruit
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the enzymes that catalyze formation of these histone “marks” to
the loci thus establishing specific cell-type and stimulus-specific
patterns of histone “marks.” Initially it was thought that these
modifications were permanent once formed. However, the discov-
ery of enzymes that also remove these “marks” has changed this
view and suggests that epigenetics may represent a very dynamic
process.
The IFNG locus undergoes complex patterns of histone modifi-
cations in response to Th1/Th2 differentiation signals (Zhou et al.,
2004; Chang and Aune, 2005, 2007; Schoenborn et al., 2007). The
IFNG locus is relatively devoid of histone “marks,” in particular
H4-Ac “marks,” in proliferating CD4+ T cells in the absence of
Th1/Th2/Th17 polarizing signals, Th0 cells. However, addition of
a specific inhibitor of histone deacetylases produces an H4-Ac pat-
tern across the IFNG locus and active IFNG transcription similar
to that observed in effector Th1 cells. This has been interpreted to
mean that both histone acetyltransferases and histone deacetylases
are recruited to the IFNG locus in Th0 cells resulting in no accu-
mulation of H4-Ac “marks.” Inhibition of histone deacetylases
allows histone acetyltransferase-catalyzed accumulation of H4-Ac
and IFNG transcription (Chang et al., 2008; Aune et al., 2009).
Stat4, Runx3, T-bet, and multiple other transcription fac-
tors are recruited to the promoter and multiple other conserved
non-coding sequence (CNS) elements across the IFNG locus in
response to Th1 polarizing signals (Zhu et al., 2010). Th1 differ-
entiation also stimulates formation of a complex pattern of H4-Ac
and H3K4-Me “marks” across the locus, modifications that pro-
mote transcription. In part, accumulation of H4-Ac across the
locus is dependent upon T-bet mediated expulsion of histone
deacetylases from the locus. Presumably these transcription fac-
tors also recruit additional histone acetyltransferases and histone
methyltransferases to the locus to form this complex epigenetic
pattern. Formation of this complex pattern of epigenetic modi-
fications is largely abrogated in the absence of Stat4 or T-bet. In
large part, these epigenetic modifications are sustained in both
memory CD4 and CD8 T cells (Northrop et al., 2006; Schoenborn
et al., 2007). Interestingly, differentiation of memory CD8 T cells
requires CD4 T cell “help” and this “helper” function is revealed
by the requirement for CD4 T cell help at the level of epigenetic
modifications at the IFNG locus in memory CD8 T cells.
In contrast to CD4 T cells, NK cells do not need to endure
additional developmental programs once they immigrate to the
periphery to rapidly respond to extracellular stimuli and tran-
scribe IFNG. Peripheral NK cells also possess a pre-existing H4-Ac
pattern of epigenetic modifications across the IFNG locus and pre-
sumably H3K4-Me modifications (Chang and Aune, 2005). This
pattern is similar but not identical to that seen in either effec-
tor Th1 or Tc1 cells differentiated in tissue culture in response
to polarizing signals or in vivo. In NK cells, the IFNG locus is
further modified by H4-Ac at additional sites across the locus
in response to stimuli that induce IFNG transcription. Thus, the
differentiation signals driving NK cell development also produce
epigenetic modifications across the IFNG locus that presum-
ably allow NK cells to respond to extracellular stimuli by rapidly
transcribing IFNG.
Th2 differentiation signals also initiates epigenetic modifica-
tions across the IFNG locus (Chang and Aune, 2007). In contrast
to the “marks” formed in response to Th1 differentiation sig-
nals, the marks formed in response to Th2 differentiation are
repressive H3K27 di- and tri-Me “marks.” Consequently, silenc-
ing of IFNG in Th2 cells, like transcriptional activation of IFNG
in Th1 cells, is an active process. These “marks” are formed at
approximately the same CNS’s that are modified in Th1 by acti-
vating “marks.” Further, key transcription factors that drive the
Th2 differentiation process, Stat6 and GATA-3 (Kaplan et al.,
1996; Zheng and Flavell, 1997), are recruited to the IFNG locus
and are required to recruit EZH2, the enzyme that catalyzes
H3K27-Me, to the locus. Thus, Stat6 and GATA-3 are recruited
to both the IFNG and IL4 loci in developing Th2 cells. How-
ever, somehow these transcription factors recruit enzymes that
catalyze formation of activating histone “marks” to the IL4 locus
and enzymes that catalyze formation of repressive histone “marks”
to the IFNG locus. Thus, Stat6 and GATA-3 are both activating and
repressive transcription factors depending upon the gene locus in
question.
Another form of histone modification is H3K9 Me. HeK9 Me
is generally associated with transcriptional repression. However,
there is also evidence that H3K9 Me occurs at gene loci that
are actively transcribed (Vakoc et al., 2005). The IFNG locus is
also modified by H3K9 Me in response to T-cell activation and
T helper cell differentiation in developing Th0, Th1, and Th2
cells (Chang and Aune, 2007). In Th0 cells and developing Th1
cells, these “marks” are sustained. In contrast, in developing Th2
cells, these marks are extinguished and replaced by H3K27-Me
marks. A general view is that the H3K27-Me “mark” is associated
with cell-type specific and stimulus-specific active transcriptional
repression while the H3K9 Me “mark” is associated with silencing
of genes in cells that lack the potential to transcribe a given gene.
One possible interpretation is that H3K9 Me serves to repress IFNG
transcription in Th0 cells but also to dampen IFNG transcription
in effector Th1 cells. In principle, this adds another layer of control
to IFNG transcription. This could be important since IFN-γ is such
a potent cytokine and excess IFN-γ production may have deleteri-
ous consequences such as excess inflammation and autoimmunity.
These results also represent a clear example of the dynamic nature
of histone modifications in differentiating cells that further our
understanding of the execution of the histone code.
DNA METHYLATION
DNA Me of CpG dinucleotides is a second major epigenetic mech-
anism to achieve silencing of transcription of specific genes during
developmental processes (Okano et al., 1999; Cedar and Bergman,
2009). In naïve CD4 T cells, CpG dinucleotides within the IFNG
introns and most, but not all IFNG distal CNS regions, and not the
promoter, are heavily methylated (Schoenborn et al., 2007). Me is
largely but not completely lost during Th1 differentiation. In con-
trast, DNA Me is largely sustained in response to Th2 and Th17
differentiation signals. Further, the IFNG promoter also becomes
hyper-methylated in these opposing lineages. Moreover, lineage
specificity of effector T helper cells exhibits plasticity during the
differentiation process such that early during the differentiation
process effector Th1 cells can be converted to effector Th2 or Th17
if exposed to those stimuli that drive Th2 or Th17 differentia-
tion. The converse is also true for effector Th2 and Th17 cells.
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Ultimately, these effector cells become permanently locked into
their respective Th1, Th2, or Th17 phenotypes.
The pattern of DNA Me at the human IFNG locus is some-
what different than the mouse (Janson et al., 2008; Dong et al.,
2013). Thus, both the IFNG promoter and a proximal conserved
nucleotide sequence, termed CNS-1, are methylated in naïve T
helper cells and Me is lost as T helper cells progress through
their differentiation paths to effector cells and memory cells. Evi-
dence suggests that the Me/de-Me status of IFNG may be clinically
relevant. IFNG is inappropriately hyper-methylated in tumor-
infiltrating lymphocytes in colon cancer, which may represent a
form of tumor-induced immunosuppression.
Comparing murine naïve CD4 T cells to NK cells demonstrates
a further distinction in DNA Me patterns at IFNG. Thus, the IFNG
first intron is heavily methylated in naïve CD4 T cells while it is
largely un-methylated in effector Th1 cells and NK cells (Tato et al.,
2004). Thus, as with histone Ac patterns at the IFNG locus, lack
of DNA Me at the IFNG locus in NK cells is consistent with their
ability to respond to external stimuli by rapidly producing IFN-γ.
There are several DNA methyltransferases (DNMT) responsi-
ble for DNA Me. It is generally thought that DNMT1 is necessary
to maintain DNA Me at the IFNG locus in CD4 T cells in the
undifferentiated state (Wilson et al., 2002). In contrast, DNMT3a
catalyzes DNA Me of the IFNG promoter in response to Th2 and
Th17 differentiation signals to sustain IFNG silencing in these
opposing lineages even if re-exposed to Th1 differentiation sig-
nals (Thomas et al., 2012). Thus, different DNMT’s are utilized to
silence IFNG transcription in naïve CD4 T cells and probably in
non-lymphoid cells than are utilized to silence IFNG transcription
in effector CD4 T cells of opposing lineages. A summary of known
transcription factors that bind to the IFNG locus and the different
epigenetic marks in T cells and NK cells is shown in Figure 1.
ENHANCERS
Analysis of epigenetic modifications, DNase hypersensitivity sites,
histone modifications, and CpG Me, has produced a “roadmap”
of the IFNG locus and has shown how this “roadmap” changes in
cells as they differentiate to actively transcribe or actively silence
IFNG. However, it cannot be inferred from these analyses whether
CNS’s undergoing epigenetic modifications in response to these
differentiation signals contribute to transcriptional activation or
repression and how this is orchestrated. Various strategies have
been employed to dissect functional properties of CNS’s across the
IFNG locus undergoing epigenetic modifications in response to
differentiation signals. These include analysis of enhancer activity
by using reporter constructs in cell lines, use of these reporter
constructs as transgenes in mice, and use of bacterial artificial
chromosomes (BAC) as transgenes in mice (Soutto et al., 2002;
Shnyreva et al., 2004; Tong et al., 2005; Hatton et al., 2006; Schoen-
born et al., 2007; Collins et al., 2010, 2012b). Typically, these BAC
transgenes have IFNG positioned in the middle of the BAC and
contain 50–100 kb of 5′ and 3′ sequence. Thus, they contain the
CNS’s that undergo epigenetic modifications in response to the
developmental signals that drive lineage choice.
Expression of IFN-γ by T cells can be thought of as proceeding
through discrete stages of development and this is recapitulated
in tissue culture models. Naïve T cells rapidly produce very low
levels of IFN-γ and IL-4 in response to TCR stimulation. The
combination of TCR stimulation and IL-12 will initiate the dif-
ferentiation process resulting in production of large quantities of
IFN-γ after several days in culture and this is also observed in vivo.
Effector Th1 cells are defined by their capacity to rapidly produce
large quantities of IFN-γ after a secondary TCR stimulation in the
absence of other stimuli, such as IL-12. This differentiation process
requires 4–7 days in most tissue culture models, which is similar to
FIGURE 1 | Schematic illustrating transcription factors that bind to individual CNS across the IFNG locus, histone “marks” across the locus, and
degree of CpG dinucleotide methylation at the different CNS inT cell and NK cell lineages.
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that observed, in vivo. The distinction between effector Th1 cells
and memory effector Th1 cells is that memory effector Th1 cells
are long-lived cells that exist in the periphery and rapidly respond
to secondary antigenic stimulation to produce large quantities of
IFN-γ. As described above, NK and NKT cells in the periphery
respond to a variety of extracellular stimuli by rapidly producing
large quantities of IFN-γ.
Thus, these different stages of differentiation that T cells endure
make it possible to ascertain if different CNS’s possess common
functions or unique functions. For example, the function of CNS-
30, positioned 30 kb upstream of human IFNG, has only been
studied using the BAC transgenic system. Deletion of CNS-30
abrogates IFNG expression in developing Th1 cells, effector Th1
cells, and memory Th1 cells. This CNS binds the transcription
factor, Runx3, and is required for RNA Pol2 recruitment to the pro-
moter providing an underlying mechanism for the requirement of
this CNS for active IFNG transcription. CNS-30 is also required
for IFNG expression by NKT cells but not by NK cells. One unex-
pected finding is that deletion of CNS-30 does not impact writing
of the histone code in T cells. Thus, formation of histone marks
across the locus is not impacted by deletion of CNS-30 while IFNG
transcription is severely compromised.
The general view is that the conserved DNA sequence of a CNS
implies function. A corollary of this argument is that CNS’s in
different species should have the same function. The mouse CNS-
22 and the human CNS-16 are evolutionary homologs. However,
their function is quite different. Mouse CNS-22 is necessary for
IFNG transcription during development of murine Th1 effector
cells. In contrast, human CNS-22 is not necessary for IFNG tran-
scription during development of human Th1 cells. In fact, human
CNS-22 possesses repressor function and deletion of human CNS-
22 results in active IFNG transcription in developing and effector
Th2 cells under conditions where IFNG transcription should
be actively repressed. These results are consistent with the idea
that conservation of DNA sequence implies function but demon-
strate that evolutionary CNS homologs do not necessarily possess
identical function.
Conserved non-coding sequence-2 (CNS-6 in mice) plays a key
role in early epigenetic remodeling of the IFNG locus in response
to Th1 differentiation signals (Shi et al., 2008). Initially, a Jak3-
dependent cytokine signal, probably IL-2 stimulates recruitment
of Stat5 to this CNS. NFAT is also recruited to this CNS. These early
signals are thought to facilitate T-bet recruitment to the promoter
and subsequent epigenetic modifications. Reporter assays reveal
that CNS-2 possesses enhancer function. However, in contrast to
its role in directing early epigenetic changes at the IFNG locus,
CNS-2 is not required for active IFNG transcription by develop-
ing effector Th1 cells. CNS-2 is necessary for active transcription
by both effector Th1 cells and effector memory Th1 cells. Thus,
CNS-2 orchestrates early epigenetic events during Th1 differentia-
tion and is absolutely required for IFNG transcription in response
to TCR stimulation by differentiated Th1 cells of both effector and
memory lineages.
An additional CNS positioned 3′ of IFNG, CNS+ 18–20, has
been examined in both reporter assays and in BAC transgenic
models. In reporter assays, this CNS lacks enhancer activity
but cooperates with CNS-2 to increase CNS-2 enhancer activity
(Shnyreva et al., 2004). Analysis of a deletion of CNS+ 18–20
in the BAC transgenic system reveals that this CNS is required
for production of IFN-γ by effector memory Th1 cells but not
by developing Th1 or effector Th1 cells that have differentiated,
in vitro (Collins et al., 2012a). Taken together, these results also
demonstrate that distinct CNSs are required to transcribe IFNG
at each stage of the Th1 differentiation pathway.
Analysis of CNS requirements for IFNG transcription by NK
and NKT cells further supports the notion that CNS functions
are not identical in all cells. NKT cells require both CNS-30 and
CNS+ 18–20 to produce IFN-γ independent of whether or not
they are stimulated via the TCR (a-galactosyl ceramide) or by the
cytokine combination, IL-12 and IL-18. NKT cells do not require
CNS-2 for active IFNG transcription. In contrast, NK cells do not
exhibit an absolute requirement for any individual CNS but rather
exhibit partial requirements for CNS-16, CNS-2, and CNS+ 18–
20 to produce IFN-γ. Thus, CNS-16 is a bi-functional enhancer
repressing IFNG transcription in Th2 cells yet activating IFNG
transcription in NK cells. Another feature of this modular design is
that defects in transcription revealed by CNS deletion are indepen-
dent of stimulus, TCR stimulation versus cytokine stimulation (IL-
12 and IL-18) but are cell-type specific. A schematic of different
CNS functions in T cells and NK cells is shown in Figure 2.
SHARED ENHANCERS
Although IL26 is deleted from rodent genomes, linkage of
IL26 and IFNG is preserved throughout evolutionary time from
zebrafish to humans (Dumoutier et al., 2000). Physical linkage of
genes over evolutionary time is generally thought to confer fitness
to a species yet why gene order may confer fitness to a species is
incompletely understood (Lercher et al., 2002, 2003). For example,
Th17 lineages express IL26 and Th1 lineages express IFNG so IL26
and IFNG should not be considered as part of a related gene family.
An alternate hypothesis would be that distal enhancer elements
FIGURE 2 | Summary of the regulation of IFNG transcription by distal
CNS at different stages of development inT cells and NK/NKT cells.
Red hearts identify CNS’s that are absolutely required for IFNG transcription
in the indicated cell lineage; pink hearts identify CNS’s that are partially
required for IFNG transcription in the indicated cell lineage. Red lightning
strikes identify CNS’s that repress IFNG transcription.
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may be shared between adjacent genes, which would require link-
age be maintained throughout evolution and this was possible to
test experimentally using the BAC transgenic model with deletions
of specific CNSs. One enhancer distal to the IL26 promoter and
−77 kb from IFNG is uniquely required for IL26 expression but
not for IFNG expression (Collins et al., 2012b). In contrast, the
CNS-30 enhancer element positioned between IL26 and IFNG is
required for both IL26 and IFNG expression. One function of this
enhancer is to facilitate recruitment of RNA pol II to promoters
of both genes. Thus, sharing of distal enhancers between adjacent
genes may contribute to evolutionary preservation of gene order.
Taken together, these studies illustrate how different cells
employ distal CNS’s to regulate transcription. Perhaps NK cells
represent the simplest pattern where multiple CNS’s cooperate to
drive IFNG transcription. Deletion of a single CNS is not suffi-
cient to abrogate transcription. In contrast, NKT cells utilize two
distal CNS’s and both are absolutely essential for IFNG transcrip-
tion. CD4 T cells exhibit a somewhat more complex usage of distal
CNS where one, two or three CNS’s are necessary to drive IFNG
transcription depending upon their stage of differentiation; devel-
oping Th1 cells, effector Th1 cells, or memory Th1 cells. As far as
it has been examined, individual CNS’s do not seem to be required
to write or sustain the histone code. Rather they seem necessary
to recruit RNA Pol II to the promoter to initiate transcription
of IFNG.
IFNG TRANSCRIPTION AND THE LONG NON-CODING RNA,
TMEVPG1 (NeST )
Approximately 1% of the genome is devoted to transcription of
protein-coding genes. Surprisingly, results from the ENCODE
project have identified multiple new species of RNA and demon-
strate that the majority of the genome is transcribed in some cell
at some point in development. One new species of RNA has been
termed long non-coding RNA (lncRNA) (Guttman et al., 2009).
LncRNAs may be either intragenic or intergenic. They may consist
of a single exon or multiple exons and introns that are spliced into
a mature RNA. All are transcribed in low abundance into long
segments of RNA, which vary between 200 to 2000 base pairs in
length, but lack coding potential because they are littered with stop
codons. In general, lncRNA genes demonstrate species to species
conservation of DNA sequence. Current estimates suggest that
1000s of lncRNAs exist in the human genome but functional and
molecular mechanisms have been elucidated in fewer than 10% of
these lncRNAs. LncRNAs have been shown to play key roles in all
developmental compartments including the immune system, as
well as to a host of human diseases including cancer, cardiac dis-
ease, and neurological conditions (Ji et al., 2003; Ishii et al., 2006;
Gupta et al., 2010; Kerin et al., 2012).
The major function of lncRNAs is to regulate expression of
protein-coding genes. For example, the lncRNA XIST, in concert
with nine other lncRNAs, is instrumental in the inactivation of the
X chromosome, a core biological process to regulate gene dosage
in females (Wutz, 2011). The lncRNAs, HOTAIR, and AIR, regulate
the HOXD and IGF2R loci, respectively, and are critical for seg-
mentation and genomic imprinting in early phases of development
(Sleutels et al., 2002). HOTAIR, also classified as a transcriptional
repressor, assembles as a molecular scaffold for histone modifying
complexes containing PRC2, but is unique in that it modulates
the HOXD locus in trans (Rinn et al., 2007; Tsai et al., 2010).
Enhancement of the IGF2/H19 locus through chromatin looping
via CTCF binding sites requires both the transcription factor p68
and the SRA lncRNA (Yao et al., 2010; Nagano and Fraser, 2011).
BRAVEHEART, a recently described lncRNA, has a significant role
in terminal differentiation of myocardial cells also by associating
with PRC2 complexes (Klattenhoff et al., 2013).
Long non-coding RNAs also function as molecular responders
within cell signaling networks. For example, two lncRNAs termed
long intergenic non-coding RNA-p21 or lincRNA-p21 and PANDA
(P21 associated ncRNA DNA damage activated) are located within
the CDKN1A locus and are regulated by p53, a potent tumor
suppressor. LincRNA-p21 negatively regulates expression of pro-
apoptotic genes conferring cell cycle regulation, whereas PANDA
responds to DNA damage by sequestration of the NF-YA transcrip-
tion factor resulting in cell survival (Huarte et al., 2010; Hung et al.,
2011). The lncRNA, NRON, is a negative regulator of the transcrip-
tion factor NFAT by forming protein:RNA complexes resulting in
sequestration of NFAT in the cytosol (Willingham et al., 2005).
Although the majority of classified lncRNAs are repressors of tran-
scription, a small subset of enhancer lncRNAs has been described
(Orom et al., 2010). HOTTIP, a third lncRNA regulator of the HOX
gene family, associates with WDR5 of the MLL/MLL1 histone
modifying complex to promote permissive Me marks on H3K4
at the HOXA locus in embryonic fibroblasts. LncRNAs have even
been shown to regulate other lncRNAs, as in the case of Jpx and
XIST. Jpx promotes expression of XIST in trans and without Jpx,
the critical process of X chromosome inactivation does not occur
(Tian et al., 2010).
Theiler’s Murine Encephalitis Virus Possible Gene 1
(TMEVPG1) also named NEttoie Theiler’s Pas Salmonella (NeST )
is the first identified enhancer lncRNA of the immune system to
regulate expression of a master cytokine such as IFN-γ (Vigneau
et al., 2003; Collier et al., 2012; Gomez et al., 2013). Located 170 kb
downstream from the IFNG gene and transcribed from the anti-
sense strand relative to IFNG, the 33 kb TMEVPG1 gene is spliced
into a 1.7 kb RNA transcript in humans (0.9 kb in mice). Initially
described in the context of an intracranial Theiler’s virus infection,
the inability to control chronic viral infection in mice maps to a
genetic deficiency within the TMEVPG1 gene. Analyses of epige-
netic regulatory marks across the TMEVPG1 promoter indicate
that it is an area of active transcription by enrichment of H3K9
and H4-Ac as well as H3K4 mono- and tri-Me. The TMEVPG1
gene is conserved among placental mammals with increasing rates
of sequence conservation between human and mouse orthologs
within the first exon and intron. Further, several Th1-specific
DNase I HS sites are found upstream to and at the TMEVPG1
promoter supporting the permissivity of the locus to Th1-specific
expression.
Functionally, TMEVPG1 is an enhancer of IFNG transcrip-
tion. The transcription factors, Stat4 and T-bet, are required for
effector Th1 cells to express TMEVPG1 and TMEVPG1, in cooper-
ation with T-bet, stimulates IFNG transcription. These results are
confirmed in a recent study of TMEVPG1 in the context of a Salmo-
nella infection in which TMEVPG1 confers protection against oral
infection by this pathogen. Although induction of a lncRNA by a
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viral pathogen has been demonstrated previously, this report is the
initial demonstration of the critical role a lncRNA plays in bacterial
infections. Thus, TMEVPG1 (NeST ) joins HOTTIP as a lncRNA
that associates with WDR5 to promote H3K4-Me of histones, a
mark associated with transcriptional activation, presumably at the
neighboring IFNG locus.
LOOPING OF CHROMATIN DOMAINS
It is now recognized that alterations in chromosome conformation
is a common mechanism to bring chromatin domains within close
proximity to one another or to exclude chromatin domains from
each other (Sajan and Hawkins, 2012). In this way, distal activat-
ing CNS can be brought into close proximity to a promoter and
distal repressive CNS can be excluded from the promoter of an
actively transcribed gene. The IFNG locus is a prime example of
this phenomenon. Alterations in conformation of the IFNG locus
proceed through discrete stages. In unstimulated naïve T cells, the
IFNG genomic locus associates with the Th2 cytokine genomic
locus and exists in an open conformation (Spilianakis et al., 2005).
TCR stimulation and subsequent activation and proliferation are
sufficient to free the IFNG genomic locus from the Th2 cytokine
genomic locus and to initiate alterations in the conformation of the
IFNG locus (Eivazova and Aune, 2004). Further alterations in con-
formation are seen as T cells differentiate along the Th1 pathway
and T-bet plays a key role in these additional changes in confor-
mation (Hadjur et al., 2009; Sekimata et al., 2009). Thus, both
Th1-independent and -dependent pathways exist that allow the
IFNG locus to adopt a new conformation. The general view is that
this new conformation recruits distal CNS with their associated
transcription factors and epigenetic modifying machinery to IFNG
to establish long-range epigenetic modifications that ultimately
facilitate recruitment of RNA Pol2 to the promoter and active
transcription.
CCCTC-binding factor or CTCF is a zinc finger transcription
factor that binds the core CCCTC sequence (Filippova et al.,
1996; Rubio et al., 2008; Phillips and Corces, 2009). One role
of CTCF is to regulate the three-dimensional structure of chro-
matin. It also functions as an insulator by defining the bound-
aries between euchromatin and heterochromatin. Three CTCF or
CCCTC-binding factor sites are located across the IFNG locus
and these are conserved between humans and mice (Hadjur et al.,
2009; Sekimata et al., 2009). One is positioned proximal to IL26,
one is located proximal to TMEVPG1 and one is located within an
IFNG intron. CTCF is typically known as a transcriptional repres-
sor and is also involved in insulator activity and regulation of
chromatin architecture (Phillips and Corces, 2009). In this way it
can define boundaries between active chromatin and heterochro-
matin. In effector Th1 cells, the two distal CTCF sites loop into
the CTCF site located within IFNG. It has been proposed that
this defines the boundaries of the IFNG locus and serves to insu-
late IFNG from the negative effects of adjacent heterochromatin.
However, adjacent TMEVPG1 is co-expressed with IFNG in effec-
tor Th1 cells. Adjacent IL26 is co-expressed with IFNG under
some conditions. Thus, an alternate hypothesis is that the CTCF
sites recruit adjacent TMEVPG1 and IL26 into the IFNG locus,
which would serve two purposes. First, localizing the TMEVPG1
gene close to the IFNG gene would permit TMEVPG1 RNA to
more easily associate with the IFNG locus. Second, localizing the
IL26 gene close to the IFNG gene would permit sharing of the
transcriptional and enhancer machinery necessary to express both
FIGURE 3 | Schematic illustration of looping of chromatin domains
within the IFNG locus. Changes in the three-dimensional (3-D) conformation
of the IFNG locus may recruit distal conserved non-coding sequences (CNS)
to the gene to regulate transcription. Distal evolutionarily conserved DNA
elements are occupied by transcription factors after initiation of T helper type
1 (Th1)/Th2 differentiation programs. These transcription factors can tether
enzymes that catalyze histone modifications, chromatin remodeling, and
other functions to these DNA elements. Changes in three-dimensional
conformation of the locus may serve to localize these DNA elements and
their associated proteins to the IFNG gene. It has been argued that CTCF
sites serve as boundary elements to insulate IFNG. An alternative hypothesis
is that CTCF sites serve to bring IL26 close to IFNG to allow it to share the
same transcriptional enhancers and to bringTMEVPG1 close to IFNG to allow
TMEVPG1 RNA to associate with the IFNG locus.
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genes. Thus, these CTCF sites may not serve to insulate IFNG from
IL26 and TMEVPG1 but rather to bring them into close proxim-
ity to each other to facilitate their function and co-expression.
Figure 3 presents a schematic illustration of how organization of
the IL26-IFNG-TMEVPG1 locus may look in two-dimensional
and three-dimensional space.
CONCLUDING REMARKS
Over the past decade, many studies have contributed to our
increased understanding of the complexities of the regulation of
gene transcription. Given the fundamental roles that cytokines
play in both the innate and adaptive immune systems and the fact
that their activities are mostly regulated at the transcriptional level,
it is easy to see how the genes that encode these proteins must be
under very tight regulation. Too little production of a cytokine
such as IFN-γ could fail to control pathogen infection leading to
bacteremia, viremia, or even death. Conversely, excess production
of cytokines such as IFN-γ could produce excess inflammation,
autoimmunity, or death.
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